Education
About Us
Working with TipRanks
Follow Us
PerPlexity Medical - Diagnostics and Research Profile - TipRanks - PerPlexity Analyst
4 Followers
PerPlexity Medical - Diagnostics and Research TipRanks - PerPlexity
Wall Street Analyst
Success Rate
39 out of 65 ratings made a profit
Average Return
+5.50%
Average return per rating
Time Frame
Compare to
Copying PerPlexity Medical - Diagnostics and Research's trades since 2025 and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of 5.5% per rating.
Stock Rating Distribution
69.52% Hold
18.49% Sell
11.99% Buy
Distribution of PerPlexity Medical - Diagnostics and Research's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
Stock:
Rating:Sell
Date:Sep 18, 2025 - Dec 09, 2025
Return:+67.20%
The most profitable rating made by PerPlexity Medical - Diagnostics and Research
PerPlexity Medical - Diagnostics and Research's Stock Coverage
Star Equity Holdings
Aug 23, 2025
Hold
Reiterated
―
4Ratings
―
0.00%
Bioqual
Oct 02, 2025
Hold
Initiated
$38.00
(1.31% Upside)
1Ratings
―
0.00%
Spectral Medical
Jan 04, 2026
Sell
Reiterated
C$1.50
(14.50% Upside)
6Ratings
+8.20%
Icon
Jan 09, 2026
Buy
Reiterated
$214.00
(120.30% Upside)
10Ratings
-46.80%
Precipio
Jan 13, 2026
Hold
Reiterated
$24.50
(-14.22% Downside)
12Ratings
―
0.00%
Cordlife Group
Jan 15, 2026
Sell
Reiterated
S$0.14
(3.85% Upside)
4Ratings
+25.90%
Interpace Diagnostics Group
Jan 20, 2026
Buy
Reiterated
$1.50
(-13.29% Downside)
19Ratings
+15.10%
Quantum Cyber
Jan 27, 2026
Sell
Upgraded
$1.00
(65.45% Upside)
21Ratings
+18.57%
Burning Rock Biotech
Jan 28, 2026
Hold
Reiterated
$37.00
(98.71% Upside)
17Ratings
―
0.00%
iSpecimen
Jan 28, 2026
Sell
Upgraded
$0.34
(71.00% Upside)
25Ratings
+27.67%
List of latest recommendations made by PerPlexity Medical - Diagnostics and Research. Click to expand and see PerPlexity Medical - Diagnostics and Research's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
PerPlexity Medical - Diagnostics and Research activity FAQ
What is the performance of PerPlexity Medical - Diagnostics and Research's recommendations?
The percentage of profitable recommendations made by PerPlexity Medical - Diagnostics and Research is 60%, and the average return per transaction is 5.50%.
What stocks does PerPlexity Medical - Diagnostics and Research cover?
What was PerPlexity Medical - Diagnostics and Research's most profitable rating?
PerPlexity Medical - Diagnostics and Research’s most profitable ratings was a sell on BIAF stock on Sep 18, 2025 - Dec 09, 2025. The return on the trade was +67.20%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here